Stock Events

Stock Events

MGC Pharmaceuticals 

0
66
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31AugExpected
Q4 2023
Next
-19.24
-18.91
-18.58
-18.24
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow H5O.MU. It's not an investment recommendation.
NVIDIA
2
NVDA
AMD
2
AMD
Intel
2
INTC
Palantir Technologies
2
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes in various therapeutic areas, including those Argent Biopharma is involved in.
Merck
MRK
Mkt Cap366B
Merck operates in similar therapeutic areas as Argent Biopharma, making them direct competitors in the pharmaceutical industry.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, competes with Argent Biopharma in developing treatments for various diseases.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the biopharmaceutical field, focusing on areas like immunology and oncology, which may overlap with Argent Biopharma's interests.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology company that develops innovative therapeutics, potentially in competition with Argent Biopharma's product pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that could compete with Argent Biopharma's offerings.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that focuses on areas such as infectious diseases, where Argent Biopharma may also be active.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that operates in various therapeutic areas, potentially competing with Argent Biopharma.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its pharmaceuticals and diagnostics divisions, competes in the development of innovative healthcare solutions.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company focusing on human health, directly competing with Argent Biopharma in several therapeutic areas.

About

ARGENT BIOPHARMA LTD
Show more...
CEO
Country
United Kingdom
ISIN
AU000000MXC6

Listings

MU
DE
H5O.MU
STU
DE
H5O0.STU
STU
DE
H5O.STU
MU
DE
H5O0.MU

0 Comments

Share your thoughts

FAQ

What is MGC Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange MGC Pharmaceuticals stocks are traded under the ticker H5O.MU.
When is the next MGC Pharmaceuticals earnings date?▼
MGC Pharmaceuticals is going to release the next earnings report on March 03, 2027.
In which sector is MGC Pharmaceuticals located?▼
MGC Pharmaceuticals operates in the Other sector.
When did MGC Pharmaceuticals complete a stock split?▼
The last stock split for MGC Pharmaceuticals was on October 30, 2023 with a ratio of 1:1000.